Introduction: Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess the value of longitudinal self- and informant reports of cognitive decline to predict Aβ positron emission tomography (PET) outcome in cognitively unimpaired middle-aged individuals. Methods: A total of 261 participants from the ALFA+ study underwent [18F]flutemetamol PET and Subjective Cognitive Decline Questionnaire (SCD-Q) concurrently, and 3 years before scan. We used logistic regressions to evaluate the ability of SCD-Q scores (self and informant) to predict Aβ PET visual read, and repeated analysis of variance to assess whether changes in SCD-Q scores relate to Aβ status. Results: Self-perception of decline in memory (odds ratio [OR] = 1...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152786/1/alzjjalz201908111.pd
Introduction: Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess t...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...
Introduction: Researchers are searching for clinical instruments to predict amyloid positivity for d...
Background: Amyloid β (Aβ) is thought to initiate a cascade of pathology culminating in Alzheimer’s ...
This study was designed to evaluate whether subjects with amyloid beta (Aβ) pathology, detected usin...
International audienceBackground and objectives: Studies are sparse regarding the association betwee...
Introduction: The value of quantitative longitudinal and regional amyloid beta (Aβ) measurements in ...
For the INSIGHT-preAD study groupInternational audienceImproved understanding is needed of risk fact...
Background: Improved understanding is needed of risk factors and markers of disease progression in p...
Background: Subjective cognitive decline (SCD) is a target for Alzheimer's disease prediction. Plasm...
Objective: Biomarkers for Alzheimer disease (AD) can detect the disease pathology in asymptomatic su...
Objective: We aimed to whether the abnormally high amyloid-β (Aβ) level in the brain among apparentl...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152786/1/alzjjalz201908111.pd
Introduction: Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess t...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...
Introduction: Researchers are searching for clinical instruments to predict amyloid positivity for d...
Background: Amyloid β (Aβ) is thought to initiate a cascade of pathology culminating in Alzheimer’s ...
This study was designed to evaluate whether subjects with amyloid beta (Aβ) pathology, detected usin...
International audienceBackground and objectives: Studies are sparse regarding the association betwee...
Introduction: The value of quantitative longitudinal and regional amyloid beta (Aβ) measurements in ...
For the INSIGHT-preAD study groupInternational audienceImproved understanding is needed of risk fact...
Background: Improved understanding is needed of risk factors and markers of disease progression in p...
Background: Subjective cognitive decline (SCD) is a target for Alzheimer's disease prediction. Plasm...
Objective: Biomarkers for Alzheimer disease (AD) can detect the disease pathology in asymptomatic su...
Objective: We aimed to whether the abnormally high amyloid-β (Aβ) level in the brain among apparentl...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152786/1/alzjjalz201908111.pd